Nakai Shigeru, Masakane Ikuto, Shigematsu Takashi, Hamano Takayuki, Yamagata Kunihiro, Watanabe Yuuzou, Itami Noritomo, Ogata Satoshi, Kimata Naoki, Shinoda Toshio, Syouji Tetsuo, Suzuki Kazuyuki, Taniguchi Masatomo, Tsuchida Kenji, Nakamoto Hidetomo, Nishi Shinichi, Nishi Hiroshi, Hashimoto Seiji, Hasegawa Takeshi, Hanafusa Norio, Fujii Naohiko, Marubayashi Seiji, Morita Osamu, Wakai Kenji, Wada Atsushi, Iseki Kunitoshi, Tsubakihara Yoshiharu
Patient Registration Committee, Japanese Society for Dialysis Therapy, Tokyo, Japan.
Ther Apher Dial. 2009 Dec;13(6):457-504. doi: 10.1111/j.1744-9987.2009.00789.x.
A nationwide statistical survey of 4098 dialysis facilities was conducted at the end of 2007, and 4052 facilities (98.88%) participated. The number of patients undergoing dialysis at the end of 2007 was determined to be 275 242, an increase of 10 769 patients (4.1%) compared with that at the end of 2006.The number of dialysis patients per million at the end of 2007 was 2154. The crude death rate of dialysis patients at the end of 2007 from the end of 2006 was 9.4%. The mean age of new patients begun on dialysis was 66.8 years and the mean age of the entire dialysis patient population was 64.9 years. For the primary diseases of new patients begun on dialysis, the percentages of patients with diabetic nephropathy and chronic glomerulonephritis were 43.4% and 23.8%, respectively. The percentages of facilities that achieved the control standard of endotoxin concentration in the dialysate solution of <0.05 EU/mL and those that achieved a bacterial count of <100 cfu/mL in the dialysate solution, as specified by the Japanese Society for Dialysis Therapy, were 93.6% and 97.4%, respectively. The percentage of patients positive for the hepatitis C virus antibody among the entire dialysis population significantly decreased from 15.95% at the end of 1999 to 9.83% at the end of 2007. The mean hemoglobin concentration in all the dialysis patients at the end of 2007 was 10.27 (+/-1.32, SD) g/dL, which has scarcely changed over the last three years. The numbers of male and female patients with a history of hip fracture were 142.9 and 339.0 per 10 000 dialysis patients, respectively, showing an extremely high prevalence among female patients. A history of hip fracture correlates with a low body mass index, serum albumin concentration, and a history of diabetes. The serum creatinine level of patients upon introduction to dialysis was 8.34 (+/-3.55) mg/dL, and the estimated glomerular filtration rate was 5.43 (+/-3.43) mL/min/1.73 m(2) for the patients who were newly begun on dialysis in 2007.
2007年末，对4098家透析机构进行了一项全国性统计调查，4052家机构（98.88%）参与了调查。2007年末接受透析治疗的患者人数为275242人，与2006年末相比增加了10769人（4.1%）。2007年末每百万人口中透析患者人数为2154人。2007年末透析患者的粗死亡率与2006年末相比为9.4%。开始透析的新患者的平均年龄为66.8岁，整个透析患者群体的平均年龄为64.9岁。对于开始透析的新患者的原发性疾病，糖尿病肾病和慢性肾小球肾炎患者的百分比分别为43.4%和23.8%。达到日本透析治疗学会规定的透析液中内毒素浓度控制标准<0.05 EU/mL以及透析液中细菌计数<100 cfu/mL的机构百分比分别为93.6%和97.4%。整个透析人群中丙型肝炎病毒抗体阳性患者的百分比从1999年末的15.95%显著下降至2007年末的9.83%。2007年末所有透析患者的平均血红蛋白浓度为10.27（±1.32，标准差）g/dL，在过去三年中几乎没有变化。每10000名透析患者中，有髋部骨折病史的男性和女性患者人数分别为142.9人和339.0人，女性患者中的患病率极高。髋部骨折病史与低体重指数、血清白蛋白浓度以及糖尿病病史相关。开始透析时患者的血清肌酐水平为8.34（±3.55）mg/dL，2007年新开始透析的患者的估计肾小球滤过率为5.43（±3.43）mL/min/1.73 m²。
